Literature DB >> 22785181

Functional outcomes of adult patients with West Nile virus admitted to a rehabilitation hospital.

Julie E Hoffman1, Karen A Paschal.   

Abstract

BACKGROUND AND
PURPOSE: The clinical manifestation of West Nile Virus (WNV) varies in individuals from mild flu-like symptoms to acute flaccid paralysis. Advanced age is the most significant risk factor for developing severe neurological disease and for death. The broad range of neurologic symptoms associated with WNV infection leads to varied body structure and function limitations and participation restrictions that may require rehabilitation. The purpose of this study is to describe the functional impairments upon admission and the functional outcomes at discharge of 48 adult patients admitted with WNV to a rehabilitation facility in the Midwest from 2002 to 2009.
METHODS: A retrospective chart review was completed on 48 patients (29 male, 19 female) with mean age 67.8 (SD = 16.6, range = 24-91) years and median age 72.5 years, admitted to inpatient rehabilitation with a diagnosis of WNV after January 1, 2002, and discharged prior to December 31, 2009. General information (sex, age, social history, employment, and living environment), past medical history, and information specific to the current hospitalization (medical conditions, functional status and activity level on admission and discharge as measured by the Functional Independence Measure [FIM], lengths of stay [LOSs] in the acute care and rehabilitation hospital, physical therapy care, discharge destination, and follow-up care provisions) were gathered. The standardized response mean (SRM) was calculated for total, motor, and cognitive FIM scores to provide insight into the effect size and the responsiveness of the FIM for the patients with WNV in this study.
RESULTS: All patients were admitted to the rehabilitation hospital from acute care hospitals following LOSs ranging from 1 to 62 days. The rehabilitation hospital LOS ranged from 2 to 304 days. These patients had significant comorbidities including hypertension (43.75%), diabetes mellitus (41.67%), acute respiratory failure (37.5%), ventilator dependency/tracheostomy (33.33%), and pneumonia (29.17%). Their admission FIM scores ranged from 13 to 116 (mean = 45.8 ± 28.2) and discharge FIM scores ranged from 18 to 121 (mean = 75.1 ± 34.2). The change in FIM during inpatient rehabilitation was statistically significant (P < .001). The calculated SRM for the total (1.06) and motor (1.12) FIM indicate a large effect size, whereas the SRM for the cognitive FIM (0.79) indicates a moderate effect. The majority of patients were discharged home or to a nursing facility (46%), skilled or extended care (38%) with a need for continued rehabilitation services. DISCUSSION AND
CONCLUSIONS: The manifestation of the WNV and functional outcomes after comprehensive rehabilitation vary from patient to patient. Higher numbers of comorbid conditions lead to more complex presentation and challenge rehabilitation professionals to design individualized plans of care to enable these patients to achieve the highest functional outcomes. Most patients require follow-up physical therapy care after discharge from rehabilitation.

Entities:  

Mesh:

Year:  2013        PMID: 22785181     DOI: 10.1519/JPT.0b013e318258bcba

Source DB:  PubMed          Journal:  J Geriatr Phys Ther        ISSN: 1539-8412            Impact factor:   3.381


  5 in total

Review 1.  Epidemiologic and clinical parameters of West Nile virus infections in humans: a scoping review.

Authors:  Man Wah Yeung; Emily Shing; Mark Nelder; Beate Sander
Journal:  BMC Infect Dis       Date:  2017-09-06       Impact factor: 3.090

2.  Arboviral Infections in Neurological Disorders in Hospitalized Patients in São José do Rio Preto, São Paulo, Brazil.

Authors:  Bruno H G A Milhim; Leonardo C da Rocha; Ana C B Terzian; Carolina C P Mazaro; Marcos T Augusto; Adriana Luchs; Nathalia Zini; Livia Sacchetto; Barbara F Dos Santos; Pedro H C Garcia; Rodrigo S Rocha; Elisabete Liso; Vânia M S Brienze; Gislaine C D da Silva; Nikos Vasilakis; Cássia F Estofolete; Maurício L Nogueira
Journal:  Viruses       Date:  2022-07-07       Impact factor: 5.818

Review 3.  Update on T cells in the virally infected brain: friends and foes.

Authors:  Shenjian Ai; Robyn S Klein
Journal:  Curr Opin Neurol       Date:  2020-06       Impact factor: 5.710

4.  Prevalence of chronic comorbidities in dengue fever and West Nile virus: A systematic review and meta-analysis.

Authors:  Alaa Badawi; Russanthy Velummailum; Seung Gwan Ryoo; Arrani Senthinathan; Sahar Yaghoubi; Denitsa Vasileva; Emma Ostermeier; Mikayla Plishka; Marcel Soosaipillai; Paul Arora
Journal:  PLoS One       Date:  2018-07-10       Impact factor: 3.240

Review 5.  Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis.

Authors:  Hamid Salimi; Matthew D Cain; Robyn S Klein
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.